Plain-English translation of NCT07636759 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are testing an artificial intelligence algorithm called DeepECG LVSD that analyzes standard heart recordings (called ECGs) to detect early heart weakness. The study will enroll about 15,000 patients and compare what the AI algorithm finds against what heart ultrasound (the current gold standard) shows, to see if the AI tool is accurate enough to use in real hospitals.
Heart weakness often goes undetected because heart ultrasounds are expensive, not widely available, and require a specialist to perform. This new treatment aims to use routinely performed heart recordings to catch heart weakness early, potentially preventing serious complications like hospitalization or heart failure.
You likely qualify if…
You likely don't qualify if…
You don't need to do anything special—this study simply uses heart tests you've already had done at the hospital. Researchers will analyze your existing heart recordings and ultrasound results, and may track whether you have any health problems over the next 30 days (like emergency visits or hospital stays). The study involves no new procedures or treatments for you.
AI-generated summary from trial data · Jun 25, 2026 · Not medical advice
South Korea